CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 5, 2022 · earnings

IMVT earnings: a positive outcome, +8.7%

On August 5, 2022, Immunovant, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.7% in the window around the event.

The move

$4.38
1d before
$4.76
Event day
$4.76
1d after
$5.46
5d after

Pre-catalyst setup

-2.2%
30-day run-up
6660%
30-day volatility
0.7×
volume spike